CORE--ANIMAL BARRIER FACILITY
CORE--ANIMAL BARRIER FACILITY
批准号:
6396727
负责人:
JEFFREY A BLUESTONE
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of the University of Chicago Cancer Research Center (UCCRC)
Animal Barrier Facilities is to provide Cancer Center members the ability
to conduct studies with rodents free of intercurrent infection with
adventitious murine pathogens. The Barriers are supported by the
facilities, programs, and staff of the University's Animal Resources
Center (ARC). The ARC's Comparative Diagnostic Laboratory(CDL) provides
expertise in rodent serology, microbiology, parasitology, and hematology.
All biological materials introduced into rodents maintained in these
facilities are evaluated by the CDL for contamination with adventitious
viruses and mycoplasma by MAP testing. The ARC conducts an extensive
Murine Health Monitoring Program to confirm that the pathogen-free status
of the barrier colonies are maintained. The program is designed to detect
variance in health status at specific time intervals. The program employs
sentinel animals monitored monthly, serum banking, evaluation of "index"
cases and close communication with investigative staff who may note
unexplained variances in their experiments. Additionally, a quarantine
program which includes extensive diagnostic evaluation is instituted for
all rodents imported from colonies obtained from non-commercial vendors.
Quarantine is essential to minimize the likelihood of introducing
unwanted murine pathogens into barrier colonies.
The rodent barrier facilities serving the UCCRC are located on the top
floor of the Franklin McLean Institute (FMI) and in the basement of
Biological Sciences Learning Center (BSLC). They are essential components
of the Cancer Research Center, providing approximately 7,925 net square
feet of animal holding and procedure space. The facilities contain
sixteen animal holding rooms, seven of which are equipped with three
Illinois cubicles. In addition to animal holding rooms, the barriers are
equipped with laboratory and procedure space. Isolator type caging
systems are employed throughout the barriers. All caging materials and
feed are autoclaved prior to use. Animals are transferred within a
separate hood or within a cubicle by animal care specialists, using
chemically disinfected forceps between cage transfers. A maximum of four
or five mice, dependent on weight, are permitted per cage. A bar coded
cage card provides encrypted information including the strain or stock,
source, and investigator. Cage cards are routinely scanned for
information which is downloaded into the ARC database that is used to
maintain accurate and detailed census information.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designer Tregs for restoring tolerance in patients with type 1 diabetes
-
批准号:9459191
-
项目类别:
-
资助金额:$335.17万
-
财政年份:2017
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Project 2 - Specificity and repertoire of Tregs in T1D
-
批准号:9151389
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2016
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
-
批准号:8672260
-
项目类别:
-
资助金额:$98.32万
-
财政年份:2014
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Innate Lymphoid Cells in Autoimmunity
-
批准号:8637675
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2013
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8728396
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8264452
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Spontaneous Autoimmune Model of Peripheral Neuropathy
-
批准号:8116742
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:7994038
-
项目类别:
-
资助金额:$118.56万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8322756
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8143503
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
-
批准号:7688822
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2009
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Core
-
批准号:7510118
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2007
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CTLA-4 functions in tolerance and autoimmunity
-
批准号:7215474
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Flow Cytometry
-
批准号:7215480
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Notch 1 in Immune Tolerance
-
批准号:6782125
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2004
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Notch 1 in Immune Tolerance
-
批准号:6876102
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2004
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Metabolism Core
-
批准号:7925411
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Diabetes Research and Training Center
-
批准号:6584737
-
项目类别:
-
资助金额:$117.83万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
PILOT AND FEASIBILITY PROGRAM
-
批准号:6612298
-
项目类别:
-
资助金额:$7.57万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CORE--ISLET PRODUCTION
-
批准号:6612293
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
海外基金